We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

PURITAN MEDICAL

Puritan Medical Products is a manufacturer of healthcare, diagnostic and critical environment products. Its portfolio... read more Featured Products: More products

Download Mobile App





Puritan Medical Exhibits Its World-Renowned Swabs and Other Product Offerings

By LabMedica International staff writers
Posted on 22 Jul 2023

Puritan Medical Products (Guilford, ME, USA), the world's most trusted manufacturer of swabs, is attending AACC 2023 where the company is exhibiting its world-renowned swabs and other products. More...

Puritan is also demonstrating its expertise in topics such as automation, pandemic response, and virus protection, participating in panel discussions, joining in-depth symposiums, and introducing its various experts to their global counterparts.

Prior to AACC 2023, Puritan attended ASM Microbe 2023 hosted in June in Houston, Texas by the American Society for Microbiology. During the event, which is the largest microbial sciences gathering in the world, Puritan highlighted its key business lines—and core product offerings—to thousands of scientists, researchers, and healthcare professionals who are at the forefront of medical advancement. At the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo, hosted by the American Association for Clinical Chemistry, Puritan is exhibiting its products and solutions at Booth #4115. Puritan is playing a pivotal part in exploring the cutting-edge science and technology that are shaping the future of laboratory medicine, with the event featuring more than 800 exhibitors and over 200 new products and services.

Puritan works hand-in-hand with its customers to create the best single-use products for reliable specimen collection and accurate diagnoses. By combining user feedback and a proprietary research manufacturing process, the company has developed a patented, intricate fiber technology that provides the highest collection and elution capacities available on the market. The company’s patented HydraFlock and PurFlock Ultra flocked swabs are made with intricate, multi-length fibers for superior specimen collection and elution. Ultimate purity and efficient cell release characteristics make PurFlock Ultra flocked swabs ideal for PCR, molecular assays, rapid tests, and forensic applications. Designed specifically for the collection of biological specimens, HydraFlock provides higher absorption capacity and complete elution. Puritan also offers dry as well as media-filled transport systems.

“Puritan has a unique opportunity to expand its international presence while also connecting with existing customers, explaining why our unique approach to customization is applicable to a wide range of industries,” said Bob Shultz, President and CFO at Puritan. “From California to Texas and other countries, Puritan changes the world for the better on a daily basis, and we couldn't be prouder to share that story with others.”

Related Links:
Puritan Medical Products 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Immunofluorescence Analyzer
IFA System
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.